1 Followers
25 Following
Sapanas

Sapanas

RSV Diagnostics Market Research Report By 2023 | Global Industry Trends, Growth Rate, Size, Analysis

RSV Diagnostics Market Highlights

Respiratory Syncytial Virus (RSV) is a virus that can cause serious respiratory infections such as pneumonia and bronchitis. The increasing incidence rate of respiratory infections, growing demand for in-vitro diagnostics, and growing neonatal population are major factors propelling the growth of the market. For instance, according to the Centres for Disease Control and Prevention, in the United States, RSV on an average lead to 57,527 hospitalizations among children below five years of age. On the other hand, some factor such as lack of availability of specific treatment options for RSV infections and the high number of other pathogens that cause similar symptoms of respiratory illness may hamper the growth of the market during the assessment period.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6217

RSV Diagnostics Market Regional Analysis

The Americas is likely to dominate the global RSV diagnostics market during the forecast period. The market growth is attributed to increasing incidences of RSV infections, increasing government funding's, and increasing infant population. Additionally, growing demand for molecular diagnostics and chromatographic immunoassays in this region owing to the high accuracy, sensitivity, and specificity these devices provide. For instance, as per the data stated by the Centres for Disease Control and Prevention, in the United States, RSV leads to an estimated 2.1 million outpatient visits among children below five years of age every year. Europe is anticipated to be the second largest market in the global RSV diagnostics market. The European market is expected to grow during the forecast period owing to the growing occurrence of RSV infections and growing government funding for respiratory diseases. Asia Pacific is expected to be the fastest growing market owing to the high population base, increasing prevalence of respiratory diseases such as pneumonia and bronchitis, and growing demand for automated healthcare testing for the accurate diagnosis of diseases. Furthermore, the Middle East and Africa are expected to show the least growth in the global RSV diagnostics market. The market growth in these regions is attributed to the constantly improving healthcare infrastructure, economic development, and rising patient awareness levels.

RSV Diagnostics Market Segmentation

The global RSV diagnostics market is segmented on the basis of the product, method, and end-user. On the basis of the product, the market is classified into kits and assays, instruments, and other products. The global RSV diagnostics market on the basis of the method is segmented into molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. The rapid antigen detection tests are further classified into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. Further, the other rapid antigen detection tests are classified into chromatographic immunoassays and optical immunoassays. Furthermore, on the basis of end-user, the market is segmented into hospitals and clinics, clinical laboratories, home care, and others.

Global RSV Diagnostics Key Players

Some of the key players in the global RSV diagnostics market are Quest Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Bio-Rad Laboratories Inc., Alere, Inc., Quidel Corporation, and others.

Access Report @ https://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/rsv-diagnostics-market-6217

Catheter Stabilization Device Market to Develop Rapidly by 2023

Catheter Stabilization Device Market Highlights:

The Global Catheter Stabilization Devices Market is expected to grow at an approximate CAGR of 7.1% during forecast period, 2018–2023. Factors such as growing demand for minimally invasive surgeries; increasing prevalence of lifestyle diseases, such as cardiovascular diseases, cancers; renal failure increase in number of surgeries which may require these devices for postoperative care; and increase in demand to reduce catheter associated complications & infections are expected to drive the market. Growing aging population contributes to increased need of catheter stabilization devices.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6944

Catheter Stabilization Device Market Segmentation:

The Global Catheter Stabilization Devices Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Catheter Stabilization Device Market Regional Analysis:

The Global Catheter Stabilization Devices Market is segmented on the basis of regions: Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounted for the major share of the market owing to the huge patient population, well-developed technology, and high healthcare expenditure. Asia Pacific accounted for the second largest market, which is followed by Europe. Asia Pacific is the fastest growing catheter stabilization devices market owing to rapidly changing healthcare sector, huge patient pool in this region, and the presence of vast opportunities for the development of this market. Increasing government support for research & development, well-developed healthcare infrastructure, and presence of geriatric population have driven the European catheter stabilization devices market. However, the Middle East & Africa has the least share in the market owing to the presence of poor and slow developing countries, especially, in African region. The Middle East held the major share of the regional market due to well-developed infrastructure and high spending.

Catheter Stabilization Device Market Key players

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

Atorvastatin API Market: 2019 Global Industry Size, Share, Growth Opportunities, Analysis, Developments Trends, Forecast to 2024

Atorvastatin API Market Highlights

The Global Atorvastatin API Market is estimated to be valued at USD 4,25,804.16 thousand by 2023 and is expected to register a CAGR of 3.34% during the forecast period.

 

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7885

 

Segment Analysis

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

 

Market Players

Market Research Future (MRFR) recognizes Teva Pharmaceutical Industries Ltd (Israel), Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Morepen Laboratories Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India) as the key players in the global atorvastatin API market.

 

Regional Analysis

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023. 

The European market is estimated to exceed USD 1,31,094.04 thousand by 2023. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the growth of the Atorvastatin API market in the region. France is the major contributor to the growth of the regional market, followed by the UK.

 

Key Findings of the Study

  • The Global Atorvastatin API Market is projected to reach over USD 4,25,804.16 thousand by 2023 at 34% CAGR during the review period of 2018 to 2023.
  • North America accounted for the largest market share with the US being the major contributor to the growth of the market.
  • The hypercholesterolemia segment is projected to register the highest CAGR of 4.09% during the forecast period owing to the rising rate of hypercholesterolemia cases.
  • Key manufacturers are adopting geographic expansions, corporate acquisitions and product launches as growth strategies.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

Arrhythmia Monitoring Devices Market - Economic Conditions, Acquisitions, Mergers, Developments and Forecast By 2024

The global arrhythmia monitoring devices market is expected to grow at a strong 7% CAGR over the forecast period from 2018 to 2023, according to a new research report from Market Research Future (MRFR). The global arrhythmia monitoring devices market is mainly driven by the growing prevalence of arrhythmia and rising technological advancement in monitoring devices. The rising healthcare expenditure in emerging regions as well as developed economies is also likely to remain a major factor in the global arrhythmia monitoring devices market’s progress over the forecast period.

 

Arrhythmia monitoring devices are used to monitor the heartbeat of patients with arrhythmias, i.e. fluctuations in the normal rate and pattern of the heartbeat. The heart beating too slowly, too fast, or irregularly can be a sign of deeper, more serious cardiovascular problems. Thus, arrhythmia monitoring devices play an important role in diagnosing cardiovascular conditions and checking their progress. Arrhythmia monitoring devices are useful in not only tracking the heartbeat of a patient over a long period of time, but also in alerting medical authorities in cases of emergency, as rapid changes in the heartbeat patterns can only indicate heart problems. Thus, their use has become widely prevalent in medical establishments all over the world, leading to progress of the global arrhythmia monitoring devices market.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6714

 

The increasing technological advancement in arrhythmia monitoring devices is likely to be a key driver for the market and a key point of contention in terms of the competition in the market. Coming up with more efficient arrhythmia monitoring devices is likely to be rewarded by success and is thus likely to be a key agenda for major players in the global arrhythmia monitoring devices market. The increasing healthcare expenditure around the world is also likely to be a major driver for the global arrhythmia monitoring devices market, as the number of monitoring devices sold in government hospitals in emerging countries is increasing rapidly. The increasing investment in private hospitals in emerging countries is thus also likely to be a major factor for the global arrhythmia monitoring devices market over the forecast period.

 

Segmentation:

The global arrhythmia monitoring devices market has been segmented based on device type, service providers, application, end use, and region.

 

On the basis of devices, the arrhythmia monitoring devices market has been classified into implantable cardiac monitors, mobile cardiac telemetry devices, resting ECG devices, ECG stress test devices, Holter monitors, and others.

 

On the basis of service providers, the market is segmented into mobile cardiac telemetry monitoring service providers, independent diagnostic testing facilities/clinics, others.

On the basis of application, the market has been classified as bradycardia, tachycardia, atrial fibrillation, ventricular fibrillation, premature contraction, conduction disorders, and others.

 

On the basis of end use, the arrhythmia monitoring devices market has been segmented into hospitals & clinics, ambulatory surgery centers, diagnostic centers, home care settings, long term care centers, emergency medical services.

 

Regional Analysis:

The global arrhythmia monitoring devices market is likely to be dominated by North America over the forecast period. Widespread availability of technologically advanced arrhythmia monitoring devices in North America, led by the U.S. and Canada, is the major driver for the regional segment. The growing prevalence of cardiac arrhythmias in the U.S., due to lifestyle factors such as sedentary lifestyle and excessive smoking, is likely to be a major driver for the arrhythmia monitoring devices market in the region over the forecast period.

 

Europe also holds a major share in the global arrhythmia monitoring devices market and is likely to remain a leading contributor due to the growing prevalence of arrhythmia in the region. According to the European Heart Network, close to 4 million deaths occur in Europe every year due to cardiovascular diseases.

 

Competitive Analysis:

Leading players in the global arrhythmia monitoring devices market include Cardiac Science Corporation, Koninklijke Philips, Welch Allyn, Nihon Kohden Corporation, BioTelemetry Inc., Biotronik, Abbott, Aurora Resurgence, Medi-Lynx Cardiac Monitoring, Preventice Solutions Inc., iRhythm Technologies Inc., Applied Cardiac Systems, Medtronic, AliveCor Inc., Fukuda Denshi, Spacelabs Healthcare, GE Healthcare, and NUUBO Smart Solutions Technologies.

 

Industry Updates:

In February 2019, CardioComm received FDA clearance for a new ECG device named HeartCheck CardiBeat.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-6714

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/arrhythmia-monitoring-devices-market-6714

Tissue Engineering Market Poised to Reach USD 53,424.00 Million by 2024

Market Research Future has Published a Cooked Research Report on the Global Tissue Engineering Market.

 

Market Highlights

The Global Tissue Engineering Market is estimated to be valued at USD 53,424.00 Million by 2024 and is expected to register a CAGR of 17.84% during the forecast period.

 

The nano-fibrous material segment dominated the global tissue engineering market, by material, and is projected to reach USD 16,235.5 Million by 2024 owing to the cost-effectiveness of the product; moreover. However, the biomimetic material segment is projected to be the fastest-growing segment during the forecast period.

 

North America dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 17.17% during the review period. The European market was the second largest in 2018. The market is projected to reach USD 16,514.6 million by the end of 2024.   

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2134

 

Segment Analysis

The global tissue engineering market has been segmented based on material, application, and region. On the basis of material, the market has been divided into nano-fibrous material, biomimetic material, composite material. The nano-fibrous material segment held the majority market share in 2018. However, the biomimetic material segment is anticipated to be the fastest-growing, followed by the composite material segment.

 

On the basis of application, the market has been divided into orthopedics, musculoskeletal and spine, cancer, skin/integumentary, dental, cardiology, urology, neurology, cord blood & cell banking, GI & gynecology. The orthopedics, musculoskeletal and spine segment accounted for the larger market share in 2018. However, the cancer segment is expected to exhibit higher CAGR during the forecast period.

 

Market Players

Market Research Future (MRFR) recognizes Stryker (US), Allergan (US), Medtronic (Ireland), Zimmer (US), Baxter International (US), Integra Life Sciences (US), Organovo Holdings Inc (US), Cook Medical (US), DePuy Synthes (US), Acelity (US) as the key players in the Global Tissue Engineering Market.

 

Regional Analysis

Geographically, the global tissue engineering market has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. As per MRFR analysis, North America was the largest market for tissue engineering in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The rising prevalence of chronic diseases is a major driving factor for the growth of the tissue engineering market in Europe.

 

Key Findings of the Study:

  • The Global Tissue Engineering Market is projected to reach over USD 53,424.00 million by 2024 at a 84% CAGR during the review period of 2019 to 2024.
  • North America accounted for the largest market share.
  • The nano-fibrous material segment is projected to register the highest CAGR of 18.08% during the forecast period.
  • Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/tissue-engineering-market-2134

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary CBD Market 2019 | Global Industry Analysis, Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast to 2025

Market Overview

The Global Veterinary CBD Market is poised to register a CAGR of 129.97% during the forecast period.

This impressive CAGR is possible due to the increasing number of household pets, the rising demand for humane practices in livestock management, and the easing of restrictions governing the use of CBD products to treat various ailments.

The market for global veterinary CBD products is already very diverse with multiple channels of sale.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/8138

 

SEGMENTATION

By Source

CBD products are derived from two principle sources. Each source produces its own strain and strength of CBD-related products and independently rank within the legal framework of nations.

  1. Marijuana-Derived: Marijuana is prized for its potent THC production but is hampered by the lack of a supporting legal framework for manufacture and processing. This is changing rapidly with marijuana being legalized in countries such as Canada and South Africa and various states in the US. Many countries are moving toward legalization the growth and sale of marijuana and are, therefore, potential markets for CBD products in the foreseeable future.

  2. Hemp-Derived: Hemp has been traditionally valued for the strength of its fiber which is used in numerous industries. With the advent of CBD products and the laws restricting marijuana production, hemp is being used as a source of THC for the production of numerous CBD items. Though it has a weaker THC count than marijuana, hemp is legal throughout the world, resulting in the larger market share for the segment.  

By Product

There is a vast array of veterinary CBD products available in the market.

  1. Food-Grade: Leading the market for global veterinary CBD products are food-grade items. This can be attributed to the increasing spending by pet owners. The US pet food market is expected to grow by 4.5% from 2018 to 2019, while the pet healthcare market is projected to reach USD 18.98 billion by 2019, growing by 4.8% from the previous year.  The segment can be further divided into:

    1. Treats: Ideal for small doses and inducing calmness

    2. Chews: Best for animals that tend to gnaw  

    3. Others: Items such as hemp capsules and hemp biscuits

  2. Therapeutic-Grade: Though the certification process for therapeutic products for animals is lengthy, the easing of restrictions on CBD products for medicinal purposes shall ensure that the segment registers the highest growth rate.

    1. Pet Supplements: CBD-infused pet supplements is a growing market increasing research on the beneficial effects of CBD in treating various mental and physiological pet afflictions.

    2. Pet CBD Oils: Used for a plethora of ailments

  3. Personal Care: These products focus on the mental health of animals, an area which has seen remarkable growth in recent years.

By Distribution Channel

The growth of the global veterinary CBD market is directly impacted by the distribution channels. The distinguishable channels are:

  1. E-Commerce: Top distribution channel for this market, it is expected to as long as THC manufacture and processing remain in the legal gray area globally.

  2. Retail Pharmacies: The primary distribution point for CBD products for household pets, with an edge over the livestock CBD market.

  3. Veterinary Clinics: The primary distribution point for the global livestock CBD market, this segment is expected to register the highest growth rate as veterinary CBD products find greater acceptance.  

  4. Others: Direct distribution from the manufacturer and mass orders for large-scale livestock farms are covered in this segment.

Key Players

  • Honest Paws (US)
  • HolistaPet (US)
  • HempMy Pet (US)
  • Canna-Pet (US)
  • Joy Organics (US)
  • Fomo Bones (US)
  • Pet Releaf (US)
  • Green Roads of Florida (US)
  • Wet Noses (US)

By Region

The global veterinary CBD market is currently concentrated in North America but there is significant untapped potential in other regions due to the increasing number of pets with a corresponding rise in spending on pets.

  • Americas
    • North America
      • US
      • Canada
    • Latin America
  • Europe
    • Western Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa
 

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/veterinary-cbd-market-8138

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/veterinary-cbd-market-8138

Nanobiosensors in Healthcare Market to Expand with Significant CAGR By 2024

Market Research Future has Published a Half-Cooked Research Report on the Global Nanobiosensors in Healthcare Market.

 

Market Highlights

The global nanobiosensors in healthcare market is expected to register 9.84% CAGR during the forecast period (2019–2024).

 

The nanobiosensors are advance analytical devices used to detect the chemical and biological substance and helps to understand and analyze the nature of the biological structure. nanobiosensors are the sensors that are made up of nanomaterials and have dimensions between 1 to 100 nanometers. The increasing prevalence of diabetes, advancement in monitoring systems, and raising awareness about advance nanobiosensors are expected to drive the growth of the market during the forecast period. For Instance, According to the report published by World Health Organization(WHO) in 2016, diabetes is a major healthcare concern in Brazil, and it affected more than 8.1% of the population, the prevalence of diabetes was more in females, and it affected more than 8.8% females in the country.

 

However, high costs involved in research and development and unwillingness toward the adoption of new treatment practices hinder the growth of the market during the forecast period.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/7993

 

Segmentation

The global nanobiosensors in healthcare market has been segmented on the basis of type, application, end user, and region.

 

On the basis of type, the market has been classified as optical nanobiosensor, electrochemical nanobiosensor, acoustic nanobiosensor, and others. The electrochemical nanobiosensor segment is expected to hold the largest market share of the nanobiosensors in healthcare market owing to its high sensitivity and real-time detection features. Based on the application, the market has been segmented into diabetes, immunoassay, cancer, pathogenic bacteria, and others. The market, by end user, has been divided into as hospitals and clinics, diagnostic centers, point of care, and others. However, based on end user point of care testing segment holds the largest market share due to low complex infrastructure and training.

 

Key Players

Some of the prominent key players in the global nanobiosensors in healthcare market are Abbott Point of Care, Inc., F. Hoffman-LA Roche Ltd., Medtronic Inc., Nano-Proprietary, Inc., Lifescan, Inc., Illuminex Corporation, Lifesensors, Inc., ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Bayer Healthcare AG, Bio-Rad Laboratories, Inc., Biosensors International Pte. Ltd., Sysmex Corporation.

 

Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The nanobiosensors in healthcare market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.

 

The European nanobiosensors in healthcare market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

 

The nanobiosensors in healthcare market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nanobiosensors in healthcare market in the Middle East & Africa has been segmented into the Middle East and Africa.

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/nanobiosensors-in-healthcare-market-7993 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Artificial Heart Market 2019, Industry Size, Share, Technology Advancement, Business Opportunities, Top Company profile, Regional Forecast to 2024

Market Research Future has Published a Half-Cooked Research Report on the Global Artificial Heart Market.

 

Market Highlights

The global artificial heart market held a market value of USD 1.2 billion in 2017 and is projected to grow at a CAGR of 15.1% over the forecast periodAn artificial heart is a prosthetic device that is implanted into the body to provide circulation and replace heart ventricles that are diseased or damaged

 

Segmentation

The global artificial heart market has been segmented into type, and end user.

By type, the market has been segmented into the heart-lung machine and mechanical heart. The mechanical heart is further segmented into total artificial hearts and ventricular assist devices (VADs). The mechanical heart segment is expected to register the highest CAGR during the forecast period due to growing demand.

On the basis of end user, the market has been segmented into Hospitals & Clinics, Specialty Centers, and others.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/7985

 

Key Players

Some of the prominent players in the global artificial heart market are SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, CryoLife, Inc., Abbott, and Thoratec Corporation.

 

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global artificial heart market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and a large number of diagnostic imaging centers.

Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.

 

Europe accounts for the second largest market and holds a healthy share in the global artificial heart market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing medical device industry due to the presence of major market players.

 

Asia-Pacific is expected to be the fastest growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

 

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

 

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/artificial-heart-market-7985 

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/artificial-heart-market-7985

Opioid Withdrawal Treatment Market - Production Value, Gross Margin Analysis, Sales, Demand, and Research Report 2025

Market Research Future has Published a Half-Cooked Research Report on the Global Opioid Withdrawal Treatment Market.

 

Market Highlights

The global opioid withdrawal treatment market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast periodOpioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/8123

 

Segmentation

The global opioid withdrawal treatment market has been segmented into drug type and distribution channel.

By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, analgesics, natural sleep supplements, and others.

On the basis of distribution channel, the market has been segmented into hospital pharmacy, retail pharmacies, and online stores.

 

Key Players

Some of the prominent players in the global opioid withdrawal treatment market are Merck & Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd, and Bayer AG among others

 

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global opioid withdrawal treatment market owing to the owing to increasing geriatric population, high prevalence of various chronic diseases, and rising adoption of opioids for the management of pain.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA) in the National Survey on Drug Use and Health (NSDUH), about 30.5 million Americans aged 12 or older were using illicit drugs in 2018. Additionally, rising demand for advanced treatment and growing healthcare expenditure is driving the growth of the market. For instance, according to the American College of Cardiology Foundation, coronary heart disease (CHD) is the leading cause of deaths attributable to CV in the US. CHD contributes to over 43.8% of death cases in the US. Additionally, in 2015, the total healthcare expenditure for CVD and stroke in the US was an estimated USD 329.7 billion. CVD and stroke accounted for 14% of total health expenditures in 2015.

Europe accounts for the second-largest market and holds a healthy share in the global opioid withdrawal treatment market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, and flourishing pharmaceutical industry due to the presence of major market players.

 

Asia-Pacific is expected to be the fastest-growing market, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, and availability of favorable insurance policies.

 

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access, and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of the healthcare industry and the rising availability of specialty care centers.

 

Access Report Details @ https://www.marketresearchfuture.com/reports/opioid-withdrawal-treatment-market-8123

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Source: http://www.marketresearchfuture.com/reports/opioid-withdrawal-treatment-market-8123

Thyroid Disorder Market Appraise to Reach USD 3,241.21 Million in 2025 end

Overview:

Booming economies across the world is experiencing a radical shift to urbanization which, in a supple way, is creating a physiological disorder that is giving rise to the prevalence of various ailments. Diseases such as obesity, thyroid, autoimmune diseases are a common byproduct of this shift and trigger thyroid disorders in many which, if not checked, in time can cause severe brain damage. The global market for the thyroid disorder is expected to rise with a moderate 3.1% CAGR during the forecast period (2013-2022) and can reach up to a valuation of USD 2400.8 million in the same period. The rising cases of thyroid disorder have become a concern for many initiating a collaborative agreement between private and public organizations to spread awareness. Efforts made by the pharmacies can be considered a tactical gambit in this context. As per the report of the International Thyroid Society, near about 20 million Americans are diagnosed with some form of thyroid disease, and around 12% can get affected by it in their lifetime. Chances of contracting the disease can aggravate if the patient has diabetes.

 

However, the treatment incurs high cost, and alternative treatment options are on the rise which can act as a headwind for the market. Side-effects of the treatment cannot be blind sighted as well. In considering the future of the market, this can seriously cause a plummeting effect.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2747

 

Industry Trend:

New research by the University of Colorado School of Medicine Department of Radiation Oncology has revealed that thyroid tumors can be treated with stereotactic body radiation therapy (SBRT). The side-effects would be far lesser than the traditional method and the treatment promises the better chance of recovery. The University of Birmingham has recently called for universal testing for thyroid function to reduce the number of miscarriages and negative neurodevelopmental effects on the baby.

Segmentation:

The global thyroid disorder market can be segmented by treatment, disease indication, route of administration and end-users.

By treatment, the market is segmented into drugs & supplements, diagnostics, and surgery.

Based on disease indication, the market includes hypothyroidism, hyperthyroidism, and others. The hypothyroidism holds the largest market share.

Based on the route of administration, the market encompasses oral, injectable, and others. High efficacy and bioavailability made the oral segment the most preferable.

On the basis of end-users, the market comprises hospitals and home use.

 

Regional Analysis:

Region-specific segmentation includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa.

The Americas are currently leading the pack with the maximum share of the market. North America is spearheading the region with a considerable number of patients and advanced technologies used in treating the disease in multiple facilities. Europe assumes the second position. However, the APAC is set to register the maximum CAGR during the forecast period as the region has two countries such as China and India which are showing considerable expansion. Market incumbents are also launching strategies to raise awareness among the populace which can further boost the sector’s revenue.

 

Market Competition:

The presence of several big shots across the globe is promising for the market as this will keep the market competitive and help it gain much from research and developments.

Some of the key players in this market are namely Allergan (Ireland), Abbott Laboratories (US), GlaxoSmithKline Plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), RLC LABS (US), AbbVie (US), Mylan (US)and others.

 

Get full report & TOC @: https://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Source: http://www.marketresearchfuture.com/reports/thyroid-disorder-market-2747

Bariatric Surgery Market Expected to Witness a Sustainable Growth over 2023

The global bariatric surgery market is expected to exhibit a robust 6.5% CAGR over the forecast period, according to a new research report from Market Research Future (MRFR). The global bariatric surgery market is driven mainly by the growing demand for bariatric surgeries from the urban population in developed economies. The growing prevalence of obesity in urban centers in the West is likely to drive the global bariatric surgery market over the forecast period.

 

Bariatric surgery is performed to pinch off the patient’s stomach so that their food intake is reduced without compensating on their hunger. Bariatric surgery is mostly performed in individuals with a body mass index of more than 40. Thus, cases of intense obesity with a chance of turning into morbid obesity are mostly the ideal application for bariatric surgeries.

 

The growing prevalence of obesity around the world is likely to be the major driver for the global bariatric surgery market over the forecast period. The global prevalence of obesity has been driven in the last few decades by the growing popularity of junk food and the growing prevalence of a sedentary lifestyle that doesn’t provide for exercise and active recreation. Bariatric surgery is one of the most direct ways of combating obesity, as the capacity for food intake is itself reduced, leading to smooth weight loss after the surgery.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5693

 

Advances in bariatric surgery are also likely to drive the demand for bariatric surgery over the forecast period. The growing demand for minimally invasive surgeries is likely to drive innovation in the bariatric surgery market over the forecast period, as manufacturers rush to fulfill the customer demand in the most efficient way possible. The growing number of patients opting for bariatric surgery is likely to drive the global bariatric surgery market over the forecast period.

 

Competitive Analysis:

Leading players in the global bariatric surgery market include Apollo Endosurgery Inc., Olympus Corporation, TransEnterix Surgical Inc., EndoGastric Solutions Inc., Medtronic, Aspire Bariatrics, Mediflex Surgical Products, Intuitive Surgical, ReShape Lifesciences Inc., Cousin Biotech, Allergan, and Johnson & Johnson Services Inc.

 

Segmentation:

The global bariatric surgery market is segmented on the basis of device, type, and end user.

On the basis of the device, the bariatric surgery market is segmented into surgical stapler gastric bands, gastric balloons, gastric emptying systems, electrical stimulation systems, and others.

On the basis of the type, the market is segmented into gastric bypass, sleeve gastrectomy, adjustable gastric band, biliopancreatic diversion with duodenal switch, and others.

On the basis of the end user, the bariatric surgery market is segmented into hospital & clinics, surgical centers, and others.

 

Regional Analysis:

The Americas hold the major share in the global bariatric surgery market due to the high prevalence of obesity in the region. The global bariatric surgery market is likely to receive strong demand from North America in the coming years due to the growing prevalence of obesity among the urban as well as rural populations in the region. The growing awareness among consumers in the region about maintaining an attractive appearance is also likely to lead to a steady rise in the bariatric surgery market in the region over the forecast period. The high disposable income of consumers in the region is also likely to be a major driver for the global bariatric surgery market over the forecast period. According to the CDC, one third of the U.S. population were obese in 2014, leading to strong prospects for the bariatric surgery market in the region.

Europe is also likely to emerge as a major regional market for bariatric surgery in the coming years due to the growing prevalence of obesity in advanced Western economies and the growing availability of government funding for research.

Asia Pacific holds a relatively small share in the global bariatric surgery market, but is likely to exhibit rapid growth over the forecast period, mainly due to the growing prevalence of diabetes in the region.

 

Table Of Content 

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

...Conitnued

 

Get full report & TOC @: https://www.marketresearchfuture.com/reports/bariatric-surgery-market-5693

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Source: http://www.marketresearchfuture.com/reports/bariatric-surgery-market-5693

Radiotherapy Market is projected to expand at a robust CAGR of 7% By 2023

Radiotherapy, also known as Radiation therapy is largely used in cancer treatment and less commonly in the treatments of thyroid disease, blood disorders, and noncancerous growths. Radiotherapy uses high-energy rays to treat the conditions.

Radiotherapy is a proven effective cancer treatment and hence, its market is growing rapidly and pervasively. Technological advancements in medical science & biotechnology have improved the outlook for cancer treatments further escalating the market on the global platform, controlling the spread of the disease sufficiently.

Acknowledging the exponential accruals, the market is garnering pervasively, Market Research Future (MRFR) in its recently published study report asserts that the global Radiotherapy market is poised to touch a valuation of USD 7 MN by 2023

registering a CAGR over 7% during the forecast period (2017 – 2023).  In 2016, the market had valued at 4.5 MN. which indicates that the market is expected to achieve a slightly lesser than the double fold growth.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/1526

 

Worldwide, cancer cases are increasing pervasively, creating a million dollar concern. On the other hand, Improving economy is proving to be a blessing in disguise that is in a way increasing the purchasing power of people, increasing the access to the modern life that is leading to the growing addictions such as tobacco and alcoholism which are the dominant risk factor developing cancer cells and tumors. And, on the other hand, these improving economic conditions are increasing access to the quality of healthcare, increasing the number of treatment centers.

Additionally, factors such as the increasing per capita healthcare expenditures, increasing population, exposures to harmful radiation, heredity reasons, and genetic mutations are driving the growth of the Radiotherapy market. Increasing governmental initiatives are supporting the market growth, spreading the awareness towards cancer and its treatments. Unavailability of comprehensive treatments especially in the developing regions presages the large scope for the market to evolve further, prompting substantial investments for R&D to bring more novelty and betterments in the radiology.

On the flip side, high costs associated with the radiotherapy, long approval time for the clinical trials along with the adverse effects associated with therapy are obstructing the market growth.  

 

Global Radiotherapy Market – Segmentations

The MRFR analysis is segmented into three key dynamics for enhanced understanding. 

By Treatment Type: Proton Therapy and X-rays, External Beam Radiotherapy (Intensity Modulated Radiation Therapy (IMRT), 3D Conformal Radiation Therapy, Image Guided Radiation Therapy (IGRT), Stereotactic Radio Surgery, Tomotherapy, and Stereotactic Body Radiation Therapy.), others.

By Application: Prostate Cancer, Breast Cancer, Lung Cancer, and others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.

 

Global Radiotherapy Market – Regional Analysis

The North American region is estimated to continue dominating the global Radiotherapy market, slicing the largest market share.  Majorly supported by the US, the growth in the market is fostered by the increasing prevalence of various types of cancer and thyroid as a result of the consequences of the wrong lifestyle, in the region.  Moreover, technological advances coupled with the increasing healthcare expenditure support the growth of the regional market.

The Radiotherapy market in the European region is expected to account for the second-largest market, following the North American market closely. Factors boosting the growth of the regional market include technological advancement and the augmented adoption of Radiotherapy to treat the growing cases of cancer occurrences.

The Asia Pacific region, heading with the improving economic conditions that are rapidly increasing the access to the quality healthcare is rapidly emerging as a profitable market for Radiotherapy.

Moreover, the increasing number of cancer patients in the region alongside the advancements in medical technology drives the market growth in the region. 

 

Global Radiotherapy Market – Competitive Analysis

The Radiotherapy market appears to be highly competitive characterized by the presence of several well-established as well as small players. Matured players incorporate strategic initiatives such as acquisition, collaboration, partnership, expansion, and technology launch in order to gain a competitive advantage and thus to maintain their positions in this market. 

 

Well-established players are increasingly investing in R&D to develop a cost-effective product portfolio and are seeking expansion through various strategic initiatives. These players tap the growing markets for expansions and strive to address the critical needs of the market with a broad range of solutions and effective and complete workflow.

 

Key Players:

Key players leading the global Radiotherapy market include Siemens (Germany), Varian (India), GE Healthcare (UK), Cardinal Health (US), Nordion (CA), Isoray (US), View ray (US), Fuji Holdings (Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), and Hologic (US).

 

Industry/ Innovation/Related News:

January 25, 2019 --- Apollo Hospitals Enterprise Limited (India), a leading hospital chain launched SE Asia's first proton cancer center - Apollo Proton Cancer Centre (APCC), which would offer Proton beam therapy considered as one of the most superior forms of radiation therapy in the treatment of cancers.

It is the first institution to offer advanced cancer treatment in Southeast Asia.  Unlike the conventional radiotherapy, Proton Therapy uses high energy proton beam (sub-atomic particles) to achieve the same impact but without the collateral damage.

January 16, 2019 --- MIM Software Inc. (the US), a leading global provider of medical imaging software solutions in the fields of radiation brachytherapy, oncology, radiology, and clinical trials among others announced receiving of FDA 510(k) clearance for its molecular radiotherapy (MRT) dosimetry.

MRT, an effective form of therapy that using radiopharmaceuticals such as Azedra (I-131 iobenguane) and Lutathera (Lu-177 DOTATATE) targets tumors based on certain receptors that these tumors express. 

 

Get full report & TOC @: https://www.marketresearchfuture.com/reports/radiotherapy-market-1526

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Ayurveda Market 2019 | Global Industry Analysis, Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast to 2023

Alternative medicine such as ayurveda is gradually entering the mainstream. Be it reduced side effects or low cost, ayurveda is gaining commercial success of late. Market Research Future (MRFR) has recently published an in-depth report on the global ayurveda market, where growth avenues are discussed at length. As per the analysis of MRFR, the ayurveda market is anticipated to register a moderate CAGR over the forecast period of 2017-2023.

 

The longstanding tradition of ayurvedic healing is now being recognized worldwide. Ayurveda has been able to gain commercial interest as the global populace is inclining towards organic and pure stuff. The efficacy of ayurveda is being evidenced by its efficacy in treating medical problems ranging from cardiovascular diseases, skin problems, diabetes, cancer, depression to sexual problems. The failure of modern medicine and side effects associated with them is further creating a supportive dais for the growth of the market.

 

With more players foraying into the ayurveda space, the global ayurveda market is poised for significant growth. new ayurveda companies are aggressively indulging in promotional activities, which has been able to evoke awareness among consumers. Furthermore, the governments of various countries are drafting ayurveda-friendly policies which is furthering the growth of the market.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/6166

 

Ayurveda has gained enormous popularity in medical tourism. As the benefits of ayurveda is becoming more visible, the trend of ayurveda medical tourism is consolidating. Various hospitals are increasingly catering to the ayurveda segment, with renowned doctors associated with them. Additionally, people across the globe are increasingly shifting to a preventive healthcare approach. Lately, people from across the globe are looking forward to wellness tourism and India has become an ayurveda & wellness hotspot.

However, the global ayurveda market might face some setbacks in the light of various impeding factors. Such factors include lack of scientific validation for ayurveda in developed countries, lack of proper regulatory framework, and the notion among people that ayurveda is a pseudoscience. other factors are lack of trained ayurveda professionals, unavailability of reimbursements, and lack of awareness.

 

Segmentation

The ayurveda market has been segmented based on application, disease pattern, source, form, end user, and distribution.

By application, the ayurveda market has been segmented into medicinal, personal care and other.

By disease pattern, the ayurveda market has been segmented into respiratory system, nervous systems, gastrointestinal track, cardiovascular system, infectious diseases, skeletal system, skin and hair, others.

By source, the ayurveda market has been segmented into vegetable (leaves and fruit, seeds, roots, bark and other) and animal (oils, bones, and other).

By form, the ayurveda market has been segmented into herbal, herbomineral, mineral and others.

By end user, the ayurveda market has been segmented into academia and research, hospitals and clinics, over and others.

By distribution, the ayurveda market has been segmented into organized, over the counter and others. 

 

Regional Analysis

Region-wise, the ayurveda market has been segmented into North America, the Middle & Africa (MEA), Europe, and Asia Pacific (APAC).

 

APAC is at the forefront of the global ayurveda market. Ayurveda originated in India, due to which the market has a strong foothold in the region. Ayurveda is immensely popular in India and allied countries of the region, where it is indigenous to their culture. Other key contributors to the APAC ayurveda market include Nepal, Japan, Sri Lanka, Indonesia, Myanmar and Pakistan. India is the largest ayurveda market within APAC and currently stands at USD 1200 Mn. In 2016, ayurveda drugs worth USD 64 Mn were exported from India.

 

With the surging popularity of ayurveda across the globe, the market is expanding from all sides. In both North America and Europe, ayurveda is gaining traction on account of heightened demand for natural therapies. The key country-specific markets within Europe includes Russia, France, Germany, and the UK, while, the US is the largest market within North America. Other significant ayurveda markets include Kazakhstan, Ukraine, Philippines, Kenya and Mauritania.

 

The MEA ayurveda market is poised to showcase moderate growth in the coming years. Ayurvedic therapies are gaining grounds in the region, especially in Africa due to its cost effectiveness. The Gulf countries are also responsible for generating a considerable portion of the global demand.

 

Competitive Landscape

Emami Group, Charak Pharma, Patanjali Ayurved Ltd., Dabur, Hamdard Laboratories, Baidyanath Group, Zandu Pharmaceutical Works Ltd., and Vicco Labs are the eminent players in the global ayurveda market.

 

TABLE OF CONTENT 

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

....Continued

 

Get full report & TOC @: https://www.marketresearchfuture.com/upcoming-reports/ayurveda-market-6166

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/upcoming-reports/ayurveda-market-6166

Vascular Closure Devices Market to Register Stable Expansion During 2017- 2023

Market Research Future published a half-cooked research report on the global vascular closure devices market.

 

Market Highlights

It is estimated that the global vascular closure devices market is expected to register a CAGR ~ 6.8% during the forecast period of 2018–2023. The global vascular closure devices market is expected to witness tremendous growth owing to the rising prevalence of numerous types of cardiovascular as well as neurovascular diseases. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations, increasing adoption rate of minimally invasive techniques are contributing towards the growth of the market. However, factors such as lack of trained medical professionals, and the post-operative complications are expected to curb the growth of the market during the forecast period.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/5704

 

On the regional basis, the vascular closure devices market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. This owes to the rise in the government initiatives, and the increased prevalence of coronary diseases in these regions. For instance, according to the data published in 2015 by the American Heart Association (AHA), about one in 7 deaths in the US is caused by coronary heart disease. Also, numerous major players are based in the US, owing to which the US has become a center for innovation in the vascular closure devices market.

 

Currently, the global vascular closure devices market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio. For example, in June 2018, Biomerics, a medical device contract manufacturer announced the acquisition of FutureMatrix Interventional, Inc. The company aims to expand its portfolio of interventional catheters used in cardiovascular and urology fields, thus strengthening its position in the market.

 

The global vascular closure devices market is segmented on the basis of product type, access, procedures, application, and end user.

 

Some of the key players in the global intraocular lens market are Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.

 

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

....Continued

 

Get full report & TOC @: https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704

Laxatives Market to Register a Robust Growth Rate By 2022

Market Synopsis:

Laxatives are used for treating constipation. Increasing cases of gastrointestinal disorders are expected to boost the demand for laxatives over the next couple of years. The study conducted by Market Research Future (MRFR) has highlighted that the global laxatives market is anticipated to expand at a moderate CAGR across the assessment period 2017 to 2022.

 

Laxatives are available without prescriptions over the OTC counters. People are aware of the effects which are likely to accelerate revenue creation for the market players. The growth pace of the pharmaceutical industry is also prognosticated to facilitate the expansion of laxatives market in the years to come.

 

The paradigm shift towards a sedentary lifestyle is anticipated to increase the burden of constipation. Also, increasing dependency on unhealthy food pattern is poised to facilitate the exponential growth of patient population in the forthcoming years. On the flip side, adverse effects associated with the medicine such as cramps, dehydration, etc. is anticipated to undermine the growth of the laxatives market over the next few years.

 

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/2772

 

Market Segmentation:

Global Laxatives market, on the basis of the mechanism of action, has been segmented into bulk forming, stimulant, osmotic, emollient, and others.

On the basis of type, the laxatives market has been bifurcated into organic and synthetic.

On the basis of route of administration, the global laxatives market has been bifurcated into oral and rectal.

 

Regional Analysis:

The global laxatives market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Among these regional segments, North America has been projected to account for the maximum share of the market through the review period. The U.S, and Canada are expected to contribute remarkably towards the development of the regional laxatives market in the forthcoming years. One of the primary factors inducing market growth is the sedentary lifestyle adopted by the population in the region. It is also expected to increase the burden of obesity, which is projected to have a favorable impact on the rising patient population of constipation. The food pattern of the region is also highly unhealthy. This, in turn, is likely to catapult the laxatives market on its growth trajectory.

 

Europe is forecasted to maintain its stand at the second spot over the next couple of years. Europe is anticipated to benefit from the increasing cases of irritable bowel syndromes witnessed in the region. This, in turn, is anticipated to boost the sales of laxatives in the years to come. The region has also been observing a drastic change in the lifestyle of the people. The dependency on an unhealthy diet, in conjunction with a physically inactive lifestyle, is expected to favor the expansion of the laxatives market over the next few years. In addition, the availability of laxatives without prescription over the OTC counters is poised to optimize the growth of the market in the region across the review period.

 

Asia Pacific is prognosticated to exhibit rapid developments over the next few years. The growth of the regional segment can be ascribed to the exponentially increasing population. A drastic rise in the patient population is expected owing to increasing population, which is projected to drive the growth of the region in the years to come. Also, the advancements in the healthcare industry are likely to boost the expansion of the industry over the next few years. The Middle East & Africa is projected to exhibit developmental opportunities. However, lack of access to standard medical services in certain regions, especially in Africa, is poised to restrict the growth of the regional segment.

 

Competitive Dashboard:

The key participants profiled in the share analysis of the global laxatives market are AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, GlaxoSmithKline, Takeda Pharmaceutical Company, and Abbott Laboratories. 

 

Get access to full Report @ https://www.marketresearchfuture.com/reports/laxatives-market-2772

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/laxatives-market-2772

Psoriasis Treatment Market to Touch US$10.68 billion by 2022

Market Synopsis

Market Research Future (MRFR) proclaims that the psoriasis treatment market is estimated to garner USD 10.68 billion, grabbing a CAGR of 7.3% during the forecast period (2016-2022). The rising risk factors like the autoimmune disease is likely to contribute to the market growth. Psoriasis can be referred to as a chronic non-contagious disease in which an individual’s immune system sends faulty signals which directs the skin cells to develop too quickly. New skin cells thus get formed in days rather than weeks which results in the skin to pile up on the surface, thereby causing patches of psoriasis. It can also affect the nails and fingers which leads to partial disability and painful disfiguration. The disease mainly affects the elbows, knees, and scalp. It can occur at any age, but persons from 50-70 years of age are most affected.

 

Get Free Sample of This Report

https://www.marketresearchfuture.com/sample_request/2769

 

Market Potential and Pitfalls

The fact that the exact etiology and cause of psoriasis is still unknown, genetics, auto-immunity, and environmental factors are the root causes. It is related to a host of co-morbidities like ophthalmologic pathologies, psoriatic arthritis, inflammatory bowel disease, and diabetes. As per WHO, 1.3% to 34.7% of the individuals suffering from psoriasis tend to develop chronic psoriatic arthritis which results in the deformation and disability of the joints. The rising screening and surging incidences of psoriasis are considered the top factors are propelling the psoriasis treatment market. With the growing risk factors like diabetes and autoimmune diseases coupled with the exposure to environmental factors like allergens and chemicals, the market is likely to evolve in the coming years.

 

Several treatments are available in the market which helps to control the symptoms of psoriasis, thereby inflating the growth over the years. The treatment methods include administering vitamin D3, steroid, immunosuppressive like methotrexate, and exposure to ultraviolet B (UVB) light. Ointments and creams of calcipotriol and corticosteroid are known to treat mild-to-moderate psoriasis effectively.

 

On the contrary, the dearth of permanent and effective treatment for psoriasis is considered to dampen the market growth across the globe. As there is as such no cure for psoriasis, most of the treatments are either temporary or symptomatic. Moreover, the patent expiry of blockbuster drugs like Enbrel, Humira, and Remicade, high cost of drug development, and side effects related to medications like liver and kidney damage and hypertension are considered to vitiate the market growth.

 

Global Psoriasis Treatment Market: Segmental Analysis

The global psoriasis treatment market has been segmented on the basis of route of administration, mechanism of action, and by drug types.

By mode of mechanism of action, the global psoriasis treatment market has been segmented into phosphodiesterase inhibitors, interleukin blockers, TNF inhibitors, and others. Among these, TNF inhibitors are likely to gain prominence in the psoriasis treatment market.

By mode of administration, the global psoriasis treatment market has been segmented into injectable, oral, and topical. Among these, oral treatment extensively popular and occupies a share of 40% in the global market.

By mode of drugs type, the global psoriasis treatment market has been segmented into biologics and small molecules. Among these, the biologics segment is likely to gain prominence in the coming years owing to their targeted actions.

 

Regional Insights

Geographically, the psoriasis treatment market span across regions namely, North America, Asia Pacific, Europe, and the Middle East & Africa.

North America is presumed to witness the largest share in the global market. The growth can be ascribed to the presence of several market giants coupled with a large patient population affected by psoriasis. This is in turn likely to generate more revenue for the market growth. People in this region are highly aware regarding the condition has resulted in an increased demand for effective treatment. Moreover, the surging R&D activities in order to develop a long-term solution for psoriasis is anticipated to encourage the market growth across the globe.

 

The Asia Pacific region is considered to expand at the fastest growth rate owing to the swiftly developing healthcare infrastructure coupled with the surging awareness regarding conditions like psoriasis. Moreover, with the affinity for natural skin care methods, effective alternative treatments can develop in order to treat such conditions.

 

Industry Updates

April 24, 2019: The FDA officials have recently approved risankizumab-rzaa which can effectively treat moderate-to-severe plaque psoriasis. The treatment has been specifically targeted for adults undergoing phototherapy or systemic therapy.

 

Competitive Dashboard

The prominent players operating in the global psoriasis treatment market comprises Johnson & Johnson, Novartis International AG, Merck and Co. Inc, Pfizer Inc, AbbVie and Amgen, and Eli Lilly. 

 

Get access to full summary @ https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Source: http://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769